Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
Establish a study cohort of adult chronic hepatitis B antiviral treatment based on the principle of responseguidedtreatment (RGT) corresponding to the child cohort, analyze the clinical cure factors of IC and IT stage adults chronic hepatitis B, and optimize the antiviral treatment plan. To determine the safety and efficacy of PD-1 antibody combined with Peg-FNa-2b in the treatment of adult NAs patients with CHB advantage.